Dr. Amin Mirhadi, MD
Claim this profileCedars-Sinai Medical Center
Studies Breast Cancer
Studies Brain Cancer
7 reported clinical trials
13 drugs studied
Area of expertise
1Breast Cancer
ER positive
HER2 negative
2Brain Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Amin Mirhadi, MD is currently running
Pembrolizumab + Stereotactic Radiation
for Glioblastoma
The purpose of this study is to assess the safety/tolerability/feasibility of pembrolizumab and radiation therapy before surgical resection in patients with recurrent glioblastoma as defined by treatment-related AEs and the number of patients who do not necessitate a delay in surgical resection, and to assess overall survival. The secondary objectives are to assess progression free survival, and to assess the T cell clonality, CD8 T cell activation and Tumor Infiltrating Lymphocyte (TIL) score after treatment
Recruiting1 award Phase 1 & 2
Upfront TAD/SNB
for Breast Cancer
The purpose of the study is to determine the recurrence rates and survival of patients with clinical T1-2N0 ER+/Her2- invasive breast cancer who have biopsy proven image detected nodal disease treated with upfront lumpectomy or mastectomy with TAD followed by adjuvant therapy. This is a prospective, single arm phase II clinical trial. Patients will be screened and enrolled per eligibility criteria. Patient, tumor, and treatment data will be documented.
Recruiting1 award Phase 23 criteria
More about Amin Mirhadi, MD
Clinical Trial Related7 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Amin Mirhadi, MD has experience with
- Pembrolizumab
- Neoadjuvant Stereotactic Radiosurgery
- Neurosurgical Resection
- RT Boost
- Trastuzumab
- Tucatinib
Breakdown of trials Amin Mirhadi, MD has run
Breast Cancer
Brain Cancer
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amin Mirhadi, MD specialize in?
Amin Mirhadi, MD focuses on Breast Cancer and Brain Cancer. In particular, much of their work with Breast Cancer has involved ER positive patients, or patients who are HER2 negative.
Is Amin Mirhadi, MD currently recruiting for clinical trials?
Yes, Amin Mirhadi, MD is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Amin Mirhadi, MD has studied deeply?
Yes, Amin Mirhadi, MD has studied treatments such as Pembrolizumab, Neoadjuvant Stereotactic Radiosurgery, Neurosurgical Resection.
What is the best way to schedule an appointment with Amin Mirhadi, MD?
Apply for one of the trials that Amin Mirhadi, MD is conducting.
What is the office address of Amin Mirhadi, MD?
The office of Amin Mirhadi, MD is located at: Cedars-Sinai Medical Center, Los Angeles, California 90048 United States. This is the address for their practice at the Cedars-Sinai Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.